Kengo Tanigawa

Kagoshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.

Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.

Journal: Oncoimmunology

Published: January 15, 2025

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma.

The Molecular Pathogenesis of Tumor-Suppressive miR-486-5p and miR-486-3p Target Genes: GINS4 Facilitates Aggressiveness in Lung Adenocarcinoma.

Journal: Cells

Published: June 20, 2023

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets.

Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets.

Journal: FEBS open bio

Published: April 01, 2023

Severe asthma remaining well-controlled after mepolizumab discontinuation: A case report and literature review.

Severe asthma remaining well-controlled after mepolizumab discontinuation: A case report and literature review.

Journal: Respirology case reports

Published: March 15, 2023

MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.

MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.

Journal: FEBS letters

Published: December 02, 2022

MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.

MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.

Journal: Molecular oncology

Published: April 28, 2022

Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma.

Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma.

Journal: Biomedicines

Published: November 08, 2021

Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target.

Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target.

Journal: Cancers

Published: December 21, 2020

FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p).

FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p).

Journal: Cells

Published: August 06, 2020

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase-positive lung cancer.

Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase-positive lung cancer.

Journal: Respirology case reports

Published: February 16, 2019

Case report: A case of eosinophilic granulomatosis with polyangitis (EGPA) concomitant with IgG4-related disease

Case report: A case of eosinophilic granulomatosis with polyangitis (EGPA) concomitant with IgG4-related disease

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Published: March 11, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026